Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Neuronetics (STIM) Shares Outstanding (Weighted Average) (2016 - 2025)

Neuronetics (STIM) has disclosed Shares Outstanding (Weighted Average) for 10 consecutive years, with $67.3 million as the latest value for Q3 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 124.88% to $67.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was $67.3 million, a 124.88% increase, with the full-year FY2024 number at $31.7 million, up 10.73% from a year prior.
  • Shares Outstanding (Weighted Average) was $67.3 million for Q3 2025 at Neuronetics, up from $63.8 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $67.3 million in Q3 2025 to a low of $25.2 million in Q1 2021.
  • A 5-year average of $33.5 million and a median of $28.5 million in 2023 define the central range for Shares Outstanding (Weighted Average).
  • Peak YoY movement for Shares Outstanding (Weighted Average): rose 3.05% in 2022, then skyrocketed 124.88% in 2025.
  • Neuronetics' Shares Outstanding (Weighted Average) stood at $25.5 million in 2021, then grew by 5.58% to $26.9 million in 2022, then grew by 6.54% to $28.7 million in 2023, then grew by 10.73% to $31.7 million in 2024, then skyrocketed by 112.1% to $67.3 million in 2025.
  • Per Business Quant, the three most recent readings for STIM's Shares Outstanding (Weighted Average) are $67.3 million (Q3 2025), $63.8 million (Q2 2025), and $61.5 million (Q1 2025).